APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-acting PrEP

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Long-acting PrEP Industry Growth and Trends Forecast to 2032

28 December 202577 pages

Choose your research edition.

Industry ResearchLong-acting PrEP Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting PrEP Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Long-acting PrEP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting PrEP Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting PrEP Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Long-acting PrEP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Long-acting PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Long-acting PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-acting PrEP include ViiV Healthcare and Gilead Sciences among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Long-acting PrEP market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Long-acting PrEP market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Long-acting PrEP market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Long-acting PrEP.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Long-acting PrEP market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Long-acting PrEP Market by Company

ViiV Healthcare

Gilead Sciences

Long-acting PrEP Segment by Type

Cabotegravir

Lenacapavir

Other

Long-acting PrEP Segment by Application

Hospital

Clinic

Other

Long-acting PrEP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting PrEP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting PrEP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting PrEP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-acting PrEP manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Long-acting PrEP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cabotegravir Table 2. Major Company of Lenacapavir Table 3. Major Company of Other Table 4. Global Long-acting PrEP Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 6. Global Long-acting PrEP Sales Market Share in Volume by Type (2021-2026) Table 7. Global Long-acting PrEP Sales by Type (2021-2026) & (US$ Million) Table 8. Global Long-acting PrEP Sales Market Share in Value by Type (2021-2026) Table 9. Global Long-acting PrEP Price by Type (2021-2026) & (US$/Unit) Table 10. Global Long-acting PrEP Sales by Type (2027-2032) & (K Units) Table 11. Global Long-acting PrEP Sales Market Share in Volume by Type (2027-2032) Table 12. Global Long-acting PrEP Sales by Type (2027-2032) & (US$ Million) Table 13. Global Long-acting PrEP Sales Market Share in Value by Type (2027-2032) Table 14. Global Long-acting PrEP Price by Type (2027-2032) & (US$/Unit) Table 15. North America Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 16. North America Long-acting PrEP Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 18. Europe Long-acting PrEP Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Long-acting PrEP Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 22. Latin America Long-acting PrEP Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Long-acting PrEP Sales by Type (2021-2026) & (US$ Million) Table 25. Long-acting PrEP Industry Trends Table 26. Long-acting PrEP Industry Drivers Table 27. Long-acting PrEP Industry Opportunities and Challenges Table 28. Long-acting PrEP Industry Restraints Table 29. Global Long-acting PrEP Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Long-acting PrEP Revenue Market Share by Company (2021-2026) Table 31. Global Long-acting PrEP Sales by Company (2021-2026) & (K Units) Table 32. Global Long-acting PrEP Sales Share by Company (2021-2026) Table 33. Global Long-acting PrEP Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Long-acting PrEP Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Long-acting PrEP Major Company Production Sites and Headquarters Table 36. Global Long-acting PrEP Company, Product Type & Application Table 37. Global Long-acting PrEP Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Long-acting PrEP by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Long-acting PrEP Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Long-acting PrEP Sales by Region (2021-2026) & (K Units) Table 42. Global Long-acting PrEP Sales Market Share in Volume by Region (2021-2026) Table 43. Global Long-acting PrEP Sales by Region (2021-2026) & (US$ Million) Table 44. Global Long-acting PrEP Sales Market Share in Value by Region (2021-2026) Table 45. Global Long-acting PrEP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Long-acting PrEP Sales by Region (2027-2032) & (K Units) Table 47. Global Long-acting PrEP Sales Market Share in Volume by Region (2027-2032) Table 48. Global Long-acting PrEP Sales by Region (2027-2032) & (US$ Million) Table 49. Global Long-acting PrEP Sales Market Share in Value by Region (2027-2032) Table 50. Global Long-acting PrEP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Long-acting PrEP Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 53. Global Long-acting PrEP Sales Market Share in Volume by Application (2021-2026) Table 54. Global Long-acting PrEP Sales by Application (2021-2026) & (US$ Million) Table 55. Global Long-acting PrEP Sales Market Share in Value by Application (2021-2026) Table 56. Global Long-acting PrEP Price by Application (2021-2026) & (US$/Unit) Table 57. Global Long-acting PrEP Sales by Application (2027-2032) & (K Units) Table 58. Global Long-acting PrEP Sales Market Share in Volume by Application (2027-2032) Table 59. Global Long-acting PrEP Sales by Application (2027-2032) & (US$ Million) Table 60. Global Long-acting PrEP Sales Market Share in Value by Application (2027-2032) Table 61. Global Long-acting PrEP Price by Application (2027-2032) & (US$/Unit) Table 62. North America Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 63. North America Long-acting PrEP Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 65. Europe Long-acting PrEP Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Long-acting PrEP Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 69. Latin America Long-acting PrEP Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Long-acting PrEP Sales by Application (2021-2026) & (US$ Million) Table 72. ViiV Healthcare Company Information Table 73. ViiV Healthcare Business Overview Table 74. ViiV Healthcare Long-acting PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. ViiV Healthcare Long-acting PrEP Product Portfolio Table 76. ViiV Healthcare Recent Development Table 77. Gilead Sciences Company Information Table 78. Gilead Sciences Business Overview Table 79. Gilead Sciences Long-acting PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Gilead Sciences Long-acting PrEP Product Portfolio Table 81. Gilead Sciences Recent Development Table 82. North America Long-acting PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 83. North America Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 84. North America Long-acting PrEP Sales Market Share by Country (2021-2026) Table 85. North America Long-acting PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 86. North America Long-acting PrEP Sales Market Share Forecast by Country (2027-2032) Table 87. North America Long-acting PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Long-acting PrEP Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Long-acting PrEP Market Share by Country (2021-2026) Table 90. North America Long-acting PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Long-acting PrEP Market Share Forecast by Country (2027-2032) Table 92. Europe Long-acting PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. Europe Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 94. Europe Long-acting PrEP Sales Market Share by Country (2021-2026) Table 95. Europe Long-acting PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 96. Europe Long-acting PrEP Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Long-acting PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Long-acting PrEP Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Long-acting PrEP Market Share by Country (2021-2026) Table 100. Europe Long-acting PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Long-acting PrEP Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Long-acting PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 104. Asia-Pacific Long-acting PrEP Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Long-acting PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 106. Asia-Pacific Long-acting PrEP Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Long-acting PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Long-acting PrEP Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Long-acting PrEP Market Share by Country (2021-2026) Table 110. Asia-Pacific Long-acting PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Long-acting PrEP Market Share Forecast by Country (2027-2032) Table 112. Latin America Long-acting PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Latin America Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 114. Latin America Long-acting PrEP Sales Market Share by Country (2021-2026) Table 115. Latin America Long-acting PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 116. Latin America Long-acting PrEP Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Long-acting PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Long-acting PrEP Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Long-acting PrEP Market Share by Country (2021-2026) Table 120. Latin America Long-acting PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Long-acting PrEP Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Long-acting PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Long-acting PrEP Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Long-acting PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 126. Middle East and Africa Long-acting PrEP Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Long-acting PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Long-acting PrEP Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Long-acting PrEP Market Share by Country (2021-2026) Table 130. Middle East and Africa Long-acting PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Long-acting PrEP Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Long-acting PrEP Distributors List Table 135. Long-acting PrEP Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Long-acting PrEP Image Figure 2. Global Long-acting PrEP Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting PrEP Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-acting PrEP Sales (2021-2032) & (K Units) Figure 5. Cabotegravir Image Figure 6. Global Cabotegravir Sales YoY Growth (2021-2032) & (K Units) Figure 7. Lenacapavir Image Figure 8. Global Lenacapavir Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Long-acting PrEP Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Long-acting PrEP Market Share by Type 2025 VS 2032 Figure 13. North America Long-acting PrEP Sales Market Share in Volume by Type in 2025 Figure 14. North America Long-acting PrEP Sales Market Share in Value by Type in 2025 Figure 15. Europe Long-acting PrEP Sales Market Share in Volume by Type in 2025 Figure 16. Europe Long-acting PrEP Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Long-acting PrEP Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Long-acting PrEP Sales Market Share in Value by Type in 2025 Figure 19. Latin America Long-acting PrEP Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Long-acting PrEP Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Long-acting PrEP Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Long-acting PrEP Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Long-acting PrEP Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Long-acting PrEP Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Long-acting PrEP Market Share by Application 2025 VS 2032 Figure 33. North America Long-acting PrEP Sales Market Share in Volume by Application in 2025 Figure 34. North America Long-acting PrEP Sales Market Share in Value by Application in 2025 Figure 35. Europe Long-acting PrEP Sales Market Share in Volume by Application in 2025 Figure 36. Europe Long-acting PrEP Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Long-acting PrEP Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Long-acting PrEP Sales Market Share in Value by Application in 2025 Figure 39. Latin America Long-acting PrEP Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Long-acting PrEP Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Long-acting PrEP Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Long-acting PrEP Sales Market Share in Value by Application in 2025 Figure 43. North America Long-acting PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Long-acting PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Long-acting PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Long-acting PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Long-acting PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Long-acting PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Long-acting PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Long-acting PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Long-acting PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Long-acting PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Long-acting PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Long-acting PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Long-acting PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Long-acting PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Long-acting PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Long-acting PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Long-acting PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Long-acting PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Long-acting PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Long-acting PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Long-acting PrEP Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Long-acting PrEP Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cabotegravir
  • Lenacapavir
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • ViiV Healthcare
  • Gilead Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Long-acting PrEP Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Long-acting PrEP Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Long-acting PrEP Market by Type
  6. 1.3.1 Cabotegravir
  7. 1.3.2 Lenacapavir
  8. 1.3.3 Other
  9. 1.4 Global Long-acting PrEP Market Size by Type
  10. 1.4.1 Global Long-acting PrEP Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Long-acting PrEP Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Long-acting PrEP Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Long-acting PrEP Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Long-acting PrEP Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Long-acting PrEP Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Long-acting PrEP Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Long-acting PrEP Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Long-acting PrEP Industry Trends
  2. 2.2 Long-acting PrEP Industry Drivers
  3. 2.3 Long-acting PrEP Industry Opportunities and Challenges
  4. 2.4 Long-acting PrEP Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Long-acting PrEP Revenue (2021-2026)
  2. 3.2 Global Top Players by Long-acting PrEP Sales (2021-2026)
  3. 3.3 Global Top Players by Long-acting PrEP Price (2021-2026)
  4. 3.4 Global Long-acting PrEP Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-acting PrEP Major Company Production Sites & Headquarters
  6. 3.6 Global Long-acting PrEP Company, Product Type & Application
  7. 3.7 Global Long-acting PrEP Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-acting PrEP Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-acting PrEP Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-acting PrEP Tier 1, Tier 2, and Tier 3
4 Long-acting PrEP Regional Status and Outlook
  1. 4.1 Global Long-acting PrEP Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Long-acting PrEP Historic Market Size by Region
  3. 4.2.1 Global Long-acting PrEP Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Long-acting PrEP Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Long-acting PrEP Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Long-acting PrEP Forecasted Market Size by Region
  7. 4.3.1 Global Long-acting PrEP Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Long-acting PrEP Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Long-acting PrEP Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Long-acting PrEP by Application
  1. 5.1 Long-acting PrEP Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Long-acting PrEP Market Size by Application
  6. 5.2.1 Global Long-acting PrEP Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Long-acting PrEP Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Long-acting PrEP Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Long-acting PrEP Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Long-acting PrEP Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Long-acting PrEP Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Long-acting PrEP Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Long-acting PrEP Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ViiV Healthcare
  2. 6.1.1 ViiV Healthcare Company Information
  3. 6.1.2 ViiV Healthcare Business Overview
  4. 6.1.3 ViiV Healthcare Long-acting PrEP Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ViiV Healthcare Long-acting PrEP Product Portfolio
  6. 6.1.5 ViiV Healthcare Recent Developments
  7. 6.2 Gilead Sciences
  8. 6.2.1 Gilead Sciences Company Information
  9. 6.2.2 Gilead Sciences Business Overview
  10. 6.2.3 Gilead Sciences Long-acting PrEP Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Gilead Sciences Long-acting PrEP Product Portfolio
  12. 6.2.5 Gilead Sciences Recent Developments
7 North America by Country
  1. 7.1 North America Long-acting PrEP Sales by Country
  2. 7.1.1 North America Long-acting PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Long-acting PrEP Sales by Country (2021-2026)
  4. 7.1.3 North America Long-acting PrEP Sales Forecast by Country (2027-2032)
  5. 7.2 North America Long-acting PrEP Market Size by Country
  6. 7.2.1 North America Long-acting PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Long-acting PrEP Market Size by Country (2021-2026)
  8. 7.2.3 North America Long-acting PrEP Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Long-acting PrEP Sales by Country
  2. 8.1.1 Europe Long-acting PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Long-acting PrEP Sales by Country (2021-2026)
  4. 8.1.3 Europe Long-acting PrEP Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Long-acting PrEP Market Size by Country
  6. 8.2.1 Europe Long-acting PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Long-acting PrEP Market Size by Country (2021-2026)
  8. 8.2.3 Europe Long-acting PrEP Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Long-acting PrEP Sales by Country
  2. 9.1.1 Asia-Pacific Long-acting PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Long-acting PrEP Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Long-acting PrEP Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Long-acting PrEP Market Size by Country
  6. 9.2.1 Asia-Pacific Long-acting PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Long-acting PrEP Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Long-acting PrEP Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Long-acting PrEP Sales by Country
  2. 10.1.1 South America Long-acting PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Long-acting PrEP Sales by Country (2021-2026)
  4. 10.1.3 South America Long-acting PrEP Sales Forecast by Country (2027-2032)
  5. 10.2 South America Long-acting PrEP Market Size by Country
  6. 10.2.1 South America Long-acting PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Long-acting PrEP Market Size by Country (2021-2026)
  8. 10.2.3 South America Long-acting PrEP Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Long-acting PrEP Sales by Country
  2. 11.1.1 Middle East and Africa Long-acting PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Long-acting PrEP Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Long-acting PrEP Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Long-acting PrEP Market Size by Country
  6. 11.2.1 Middle East and Africa Long-acting PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Long-acting PrEP Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Long-acting PrEP Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Long-acting PrEP Value Chain Analysis
  2. 12.1.1 Long-acting PrEP Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Long-acting PrEP Production Mode & Process
  7. 12.2 Long-acting PrEP Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Long-acting PrEP Distributors
  10. 12.2.3 Long-acting PrEP Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst